Literature DB >> 27304487

Effect of Intervention in Mast Cell Function Before Reperfusion on Renal Ischemia-Reperfusion Injury in Rats.

Fei Tong1, Lei Luo, Daojun Liu.   

Abstract

BACKGROUND/AIMS: Mast cells are sparsely distributed in the kidneys under normal conditions; however, the number of mast cells increases dramatically during renal ischemia/reperfusion injury (RI/RI). When mast cells are stimulated, numerous mediators are released, and under pathological conditions, they produce a wide range of biological effects. The aim of this study was to investigate the effect of intervention in mast cell function before reperfusion on RI/RI.
METHODS: Sprague-Dawley (SD) rats (n=50) were randomized into five groups: sham group, ischemia/reperfusion (I/R) group, cromolyn sodium treatment group (CS+I/R group), ketotifen treatment group (K+I/Rgroup), and compound 48/80 treatment group (C+I/R group). I/R injury was induced by bilateral renal artery and vein occlusion for 45 min followed by 24 h of reperfusion. The agents were intravenously administered 5 min before reperfusion through the tail vein. The serum levels of blood urea nitrogen(BUN), serum creatinine (Scr) and histamine and the kidney levels of malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) were assessed. The expression of intracellular adhesion molecule-1 (ICAM-1) in renal tissue was also measured.
RESULTS: I/R injury resulted in severe renal injury, as demonstrated by a large increase in injury scores; serum levels of BUN, Scr and histamine; and kidney levels of MDA, TNF-α, and IL-6; this was accompanied by reduced SOD activity and upregulated ICAM-1 expression. Treatment with cromolyn sodium or ketotifen markedly alleviated I/R-mediated kidney injury, whereas compound 48/80 further aggravated kidney injury.
CONCLUSION: Intervention in mast cell activity prior to reperfusionhas a strong effect on RI/RI.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27304487     DOI: 10.1159/000443437

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

1.  [Evaluation of renal tissue ischemia-reperfusion injury with ultrasound radiation force and targeted microbubbles].

Authors:  Bao-Ping Wang; Li-Hong Luo; Feng-Lin Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

Review 2.  Histamine in the kidneys: what is its role in renal pathophysiology?

Authors:  Cristina Grange; Maura Gurrieri; Roberta Verta; Roberto Fantozzi; Alessandro Pini; Arianna Carolina Rosa
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

Review 3.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

4.  Diabetes aggravates renal ischemia and reperfusion injury in rats by exacerbating oxidative stress, inflammation, and apoptosis.

Authors:  Dao-Jing Gong; Lei Wang; Yuan-Yuan Yang; Jian-Jian Zhang; Xiu-Heng Liu
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

Review 5.  The implications of histamine metabolism and signaling in renal function.

Authors:  Anastasia V Sudarikova; Mikhail V Fomin; Irina A Yankelevich; Daria V Ilatovskaya
Journal:  Physiol Rep       Date:  2021-04

6.  Sustained local inhibition of thrombin preserves renal microarchitecture and function after onset of acute kidney injury.

Authors:  Ian Vargas; Daniel J Stephenson; Margaret Baldwin; Joseph P Gaut; Charles E Chalfant; Hua Pan; Samuel A Wickline
Journal:  Nanomedicine       Date:  2021-07-23       Impact factor: 5.307

7.  Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(l-lysine) block copolymer: potential implications on diabetic nephropathy.

Authors:  Fei Tong
Journal:  Int J Nanomedicine       Date:  2017-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.